vidarabine phosphate has been researched along with methotrexate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Akutsu, M; Bai, L; Furukawa, Y; Ichikawa, A; Kano, Y; Kon, K; Suzuki, K; Tsunoda, S | 1 |
Carlesso, A; Chevet, E; Chintha, C; Doultsinos, D; Eriksson, LA; Paton, AW; Paton, JC; Samali, A | 1 |
2 other study(ies) available for vidarabine phosphate and methotrexate
Article | Year |
---|---|
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Cell Survival; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Synergism; Etoposide; Humans; Hydroxyurea; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Methotrexate; Neoplastic Stem Cells; Tumor Cells, Cultured; Vidarabine; Vidarabine Phosphate; Vincristine | 2000 |
Peptidomimetic-based identification of FDA-approved compounds inhibiting IRE1 activity.
Topics: Cefoperazone; Cell Line, Tumor; Drug Approval; Endoplasmic Reticulum Stress; Endoribonucleases; Enzyme Inhibitors; Humans; Leucovorin; Methotrexate; Molecular Structure; Peptidomimetics; Protein Binding; Protein Domains; Protein Serine-Threonine Kinases; Signal Transduction; Unfolded Protein Response; United States; United States Food and Drug Administration; Vidarabine Phosphate | 2021 |